HPC
NGVT icon

HM Payson & Co’s Ingevity NGVT Stock Holding History

HM Payson & Co’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$4K – 907
2020
Q1 		$4K Hold
100
– – ﹤0.01% 830
2019
Q4 		$9K Hold
100
– – ﹤0.01% 814
2019
Q3 		$8K Sell
100
-91
-48% -$8.11K ﹤0.01% 837
2019
Q2 		$20K Buy
+191
New +$19.2K ﹤0.01% 731

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBCM
Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return
AAM
Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

HM Payson & Co's NGVT Position: Q2 2020 in Review

HM Payson & Co sold out of Ingevity (NGVT) in Q2 2020, closing a stake of 100 shares — an estimated $4K sold.

HM Payson & Co first reported a position in NGVT in Q2 2019 and held it in 4 quarters. The position peaked at $20K in Q2 2019. 294 funds tracked by Wall St. Rank hold NGVT as of Q2 2020.

  • HM Payson & Co reported no remaining Ingevity position as of Q2 2020 after selling out during the quarter.
  • HM Payson & Co sold 100 Ingevity shares in Q2 2020, an estimated $4K.
  • HM Payson & Co first reported a position in Ingevity in Q2 2019 and held it in 4 quarters.
  • HM Payson & Co's Ingevity position peaked at $20K in Q2 2019.
  • 294 funds tracked by Wall St. Rank held Ingevity as of Q2 2020.

Based on HM Payson & Co's 13F filing for Q2 2020, filed 13 Aug 2020.